Fresenius Medical Care AG

Company Snapshot

Founded: 1996
Entity Type: Public
Employees: 111,513
Region: U.S.
Revenue: $22,199.3 Millions
Revenue Year: 2025
Headquarter: Bad Homburg, Germany
Key Geographics: U.S., Germany, Rest of the World
Corporate Address: Else-Kröner-Straße 1 61352 Bad Homburg v.d. Höhe Germany Tel. +49-6172-6090 www.freseniusmedicalcare.com

Company Overview

Fresenius Medical Care AG offers products and services for patients with renal diseases, with a primary focus on CKD and ESRD. It operates across the whole dialysis value chain, encompassing the design and manufacture of dialysis equipment and consumables, ownership and management of an extensive international network of dialysis clinics, and the delivery of comprehensive services supporting long-term CKD care. Fresenius Medical's portfolio spans hemodialysis and peritoneal dialysis systems, clinical services, and integrated care models. It has a commercial presence in CKD-related technologies across more than 150 global markets. Its R&D pipeline includes advanced dialysis machines, water treatment technologies, dialyzers, digital and remote patient monitoring platforms, and products addressing both acute and chronic renal therapies.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Fresenius Medical Care AG In Reports

Global Renal Disease Treatments: Products and Therapies

Discover insights into the global renal disease treatments market, including product types, disease segments, dialysis, transplantation, end users and competitive dynamics through 2031.

Chronic Kidney Disease: Global Markets and Technologies

BCC Research detailed report on chronic kidney disease market technologies, providing data from 2024, estimates for 2025, projections of compound annual growth rates through 2030.

Global Outpatient Clinics Market

BCC Research Report: Dive into Outpatient Clinics Market report includes global revenue for base year data of 2023 and estimated data for the forecast period 2024 through 2029.

Company's Business Segments

  • Care Delivery : This segment is responsible for environmental management in dialysis clinics.
  • Care Enablement : This segment is accountable for sustainable manufacturing, product development, supply chain, and sales operations.

Applications/End User Industries

  • Healthcare
AI Sentiment